Back to Search
Start Over
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, openālabel study.
- Source :
- American Journal of Hematology; Jul2022, Vol. 97 Issue 7, pE226-E229, 4p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 03618609
- Volume :
- 97
- Issue :
- 7
- Database :
- Complementary Index
- Journal :
- American Journal of Hematology
- Publication Type :
- Academic Journal
- Accession number :
- 157398090
- Full Text :
- https://doi.org/10.1002/ajh.26554